Published in J Clin Invest on October 01, 1971
Immunoreactive forms of circulating parathyroid hormone in primary and ectopic hyperparathyroidism. J Clin Invest (1974) 1.30
Subunits of human chorionic gonadotropin: unbalanced synthesis and secretion by clonal cell strains derived from a bronchogenic carcinoma. Proc Natl Acad Sci U S A (1973) 1.19
Twenty-five years of PTHrP progress: from cancer hormone to multifunctional cytokine. J Bone Miner Res (2012) 1.14
Lymphoma with hypercalcemia. Can Med Assoc J (1974) 1.12
Mediastinal hyperfunctioning parathyroid tumors: review of 14 cases. Ann Surg (1973) 1.09
Phaeochromocytoma and hypercalcaemia. Postgrad Med J (1976) 0.85
The differentiation of primary hyperparathyroidism from the hypercalcemia of malignancy. Ann Surg (1975) 0.84
Immunochemical localization of parathyroid hormone in cancer tissue from patients with ectopic hyperparathyroidism. J Clin Invest (1974) 0.82
Burn scar carcinoma and hypercalcemia. Ann Surg (1974) 0.82
Ectopic apudocarcinomas and associated endocrine hyperplasias of the foregut. Ann Surg (1975) 0.80
Tumour-associated hormonal products. J Clin Pathol Suppl (R Coll Pathol) (1974) 0.80
The pathophysiology and clinical aspects of hypercalcemic disorders. West J Med (1978) 0.78
Parathyroid hormone-related protein and hypercalcemia in patients with metastatic melanoma: case report and review. Am J Clin Oncol (2003) 0.77
Tumor hypercalcemia. Calif Med (1973) 0.76
Hypercalcemia, pneumothorax and pneumoperitoneum in a patient with pulmonary mycobacteriosis and esophageal carcinoma. West J Med (1980) 0.75
Association of ectopically produced hyperparathyroidism with hepatoma. Calif Med (1973) 0.75
Cell differentiation and the biological significance of inappropriate tumour products. Proc R Soc Med (1977) 0.75
Recognizing hyperparathyroidism caused by ectopic production of a substance resembling parathyroid hormone. Can Med Assoc J (1981) 0.75
Cancer Diagnostics via Ultrasensitive Multiplexed Detection of Parathyroid Hormone-Related Peptides with a Microfluidic Immunoarray. Anal Chem (2016) 0.75
Radioimmunoassay of human parathyroid hormone in serum. J Clin Invest (1971) 3.67
Parathyroid hormone in plasma in adenomatous hyperparathyroidism, uremia, and bronchogenic carcinoma. Science (1966) 2.77
Immunochemical heterogeneity of parathyroid hormone in plasma. J Clin Endocrinol Metab (1968) 2.41
Production of parathyroid hormone by nonparthyroid tumors. J Clin Endocrinol Metab (1967) 2.00
Hypercalcemia and increased parathyroid-hormone activity in a primary hepatoma. Studies before and after hepatic transplantation. N Engl J Med (1970) 1.83
Evidence for a precursor to circulating parathyroid hormone. Proc Natl Acad Sci U S A (1970) 1.81
Native human parathyroid hormone: an immunochemical investigation. Proc Natl Acad Sci U S A (1970) 1.77
Pseudohyperparathyroidism. Medicine (Baltimore) (1966) 1.70
Human parathyroid hormone: glandular and secreted molecular species. Am J Med (1971) 1.66
The relation of age and sex to distribution of values in healthy adults of serum calcium, inorganic phosphorus, magnesium, alkaline phosphatase, total proteins, albumin, and blood urea. J Lab Clin Med (1969) 1.50
Some thoughts on the nature of ectopic parathyroid hormones. Am J Med (1971) 1.39
Evidence for parathyroid hormone in nonparathyroid tumors associated with hypercalcemia. Cancer Res (1965) 1.30
Synthesis and secretion of parathyroid hormone in vitro. Am J Med (1971) 1.17
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med (2001) 16.81
A gene expression database for the molecular pharmacology of cancer. Nat Genet (2000) 13.31
Involutional osteoporosis. N Engl J Med (1986) 8.20
MedMiner: an Internet text-mining tool for biomedical information, with application to gene expression profiling. Biotechniques (1999) 5.56
Perspective. How many women have osteoporosis? J Bone Miner Res (1992) 4.99
Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab (1998) 4.28
Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med (1992) 4.19
Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy. N Engl J Med (1982) 3.77
Radioimmunoassay of human parathyroid hormone in serum. J Clin Invest (1971) 3.67
Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis. J Clin Invest (1981) 3.60
The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res (2000) 3.38
Epidemiology of vertebral fractures in women. Am J Epidemiol (1989) 3.27
Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest (2000) 2.94
Epidemiology of fractures of the proximal femur in Rochester, Minnesota. Clin Orthop Relat Res (1981) 2.93
Changes in bone mineral density of the proximal femur and spine with aging. Differences between the postmenopausal and senile osteoporosis syndromes. J Clin Invest (1982) 2.92
Fractures after rheumatoid arthritis. A population-based study. Arthritis Rheum (1984) 2.85
Evidence of estrogen receptors in normal human osteoblast-like cells. Science (1988) 2.85
Epidemiologic features of humeral fractures. Clin Orthop Relat Res (1982) 2.79
Brownian dynamics of cytochrome c and cytochrome c peroxidase association. Science (1988) 2.78
Osteoporosis is a toxic effect of long-term etretinate therapy. Arch Dermatol (1995) 2.78
EQUIL2: a BASIC computer program for the calculation of urinary saturation. J Urol (1985) 2.71
Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology (1999) 2.69
Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone (1999) 2.69
Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology (1999) 2.65
Long-term fracture prediction by bone mineral assessed at different skeletal sites. J Bone Miner Res (1993) 2.59
Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study. Ann Intern Med (1996) 2.51
Secular trends in the incidence of hip fractures. Calcif Tissue Int (1987) 2.40
Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels. J Bone Miner Res (1990) 2.39
Osteoporosis and the risk of hip fracture. Am J Epidemiol (1986) 2.35
Cardio-selective beta-blockade. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1968) 2.33
Molecular evidence that the myxozoan protists are metazoans. Science (1994) 2.29
Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology (1999) 2.27
Vertebral fractures predict subsequent fractures. Osteoporos Int (1999) 2.24
Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium. J Clin Invest (1979) 2.21
Acquired hyperoxaluria, nephrolithiasis, and intestinal disease. Description of a syndrome. N Engl J Med (1972) 2.21
Evidence for two distinct syndromes of involutional osteoporosis. Am J Med (1983) 2.17
Incidence of Colles' fracture in a North American community. Am J Public Health (1982) 2.17
Isolation and characterization of osteoblast precursor cells from human bone marrow. J Bone Miner Res (1996) 2.16
Relationship of glucocorticoid dosage to serum bone Gla-protein concentration in patients with rheumatologic disorders. Arthritis Rheum (1990) 2.03
Risk factors for squamous cell carcinoma of the oesophagus. Br J Surg (1996) 2.03
Rates of bone loss in the appendicular and axial skeletons of women. Evidence of substantial vertebral bone loss before menopause. J Clin Invest (1986) 2.01
Risk factors for spinal osteoporosis in men. Am J Med (1983) 2.00
Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac. Blood (1995) 1.99
Treatment of primary hyperparathyroidism. Am J Med (1974) 1.98
Development and characterization of a conditionally immortalized human fetal osteoblastic cell line. J Bone Miner Res (1995) 1.97
Epidemiology of sarcopenia. J Am Geriatr Soc (2000) 1.97
Primary hyperparathyroidism: a prospective clinical study. Am J Med (1971) 1.93
Specificity of somatostatin receptor scintigraphy: a prospective study and effects of false-positive localizations on management in patients with gastrinomas. J Nucl Med (1999) 1.92
Skeletal effects of estrogen. Endocr Rev (1994) 1.91
Relative contributions of aging and estrogen deficiency to postmenopausal bone loss. N Engl J Med (1984) 1.90
Identification of a novel TGF-beta-regulated gene encoding a putative zinc finger protein in human osteoblasts. Nucleic Acids Res (1995) 1.89
Classification of vertebral fractures. J Bone Miner Res (1991) 1.89
Etiology of Barrett's metaplasia and esophageal adenocarcinoma. Cancer Epidemiol Biomarkers Prev (1997) 1.88
Biochemistry and physiology of taurine and taurine derivatives. Physiol Rev (1968) 1.88
Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan. J Clin Endocrinol Metab (1995) 1.84
Role of calcium intake in modulating age-related increases in parathyroid function and bone resorption. J Clin Endocrinol Metab (1996) 1.79
Native human parathyroid hormone: an immunochemical investigation. Proc Natl Acad Sci U S A (1970) 1.77
Bone density and fracture risk in men. J Bone Miner Res (1998) 1.77
Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial. J Clin Invest (1998) 1.75
Measurement of atherosclerotic carotid plaque size in vivo using high resolution magnetic resonance imaging. Circulation (1998) 1.74
Comparison of sex steroid measurements in men by immunoassay versus mass spectroscopy and relationships with cortical and trabecular volumetric bone mineral density. Osteoporos Int (2008) 1.73
Extent of Barrett's metaplasia: a prospective study of the serial change in area of Barrett's measured by quantitative endoscopic imaging. Gastrointest Endosc (1997) 1.72
Prevalence and incidence of vertebral deformities. Osteoporos Int (1993) 1.72
Familial benign hypercalcemia. J Pediatr (1972) 1.71
SLC26A4/PDS genotype-phenotype correlation in hearing loss with enlargement of the vestibular aqueduct (EVA): evidence that Pendred syndrome and non-syndromic EVA are distinct clinical and genetic entities. J Med Genet (2005) 1.71
Assessing forearm fracture risk in postmenopausal women. Osteoporos Int (2009) 1.71
Increase in serum bone gamma-carboxyglutamic acid protein with aging in women. Implications for the mechanism of age-related bone loss. J Clin Invest (1983) 1.69
Human parathyroid hormone: glandular and secreted molecular species. Am J Med (1971) 1.66
Iodine-131-metaiodobenzylguanidine scintigraphy in preoperative and postoperative evaluation of paragangliomas: comparison with CT and MRI. J Nucl Med (1993) 1.65
Avian osteoclasts as estrogen target cells. Proc Natl Acad Sci U S A (1991) 1.65
Diagnosis of osteoporosis: usefulness of photon absorptiometry at the radius. J Nucl Med (1977) 1.63
Effect of raloxifene on bone mineral density in premenopausal women at increased risk of breast cancer. J Clin Endocrinol Metab (2006) 1.60
Inhibition of hydroxyapatite crystal growth by bone-specific and other calcium-binding proteins. Biochemistry (1986) 1.57
Relationship between body composition and bone mass in women. J Bone Miner Res (1996) 1.57
Estimation of body fatness by air displacement plethysmography in African American and white children. Pediatr Res (2001) 1.55
The recognition and isolation from urine and serum of a peptide inhibitor to calcification. Johns Hopkins Med J (1967) 1.54
Hallux valgus assessment: report of research committee of American Orthopaedic Foot and Ankle Society. Foot Ankle (1984) 1.52
Histomorphometric analysis of iliac crest bone biopsies in placebo-treated versus fluoride-treated subjects. Osteoporos Int (1995) 1.51
Cytotoxic efficiency and effect on tumour growth of heterospecific antilymphocytic and antitumour sera. Nature (1970) 1.51
Effect of combined therapy with sodium fluoride, vitamin D and calcium in osteoporosis. Am J Med (1972) 1.50
Differential effects of endocrine dysfunction on the axial and the appendicular skeleton. J Clin Invest (1982) 1.48
Comparative effect of two strains of C. parvum on phagocytic activity and tumour growth. Nature (1968) 1.47
Relations of calcitonin and gastrin in the Zollinger-Ellison syndrome and medullary carcinoma of the thyroid. N Engl J Med (1973) 1.47
Differentiation of human marrow stromal precursor cells: bone morphogenetic protein-2 increases OSF2/CBFA1, enhances osteoblast commitment, and inhibits late adipocyte maturation. J Bone Miner Res (1999) 1.44
Relation of acanthosis nigricans to hyperinsulinemia and insulin sensitivity in overweight African American and white children. J Pediatr (2001) 1.43
Bone densitometry and clinical decision-making in osteoporosis. Ann Intern Med (1988) 1.43
The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated. Endocrinology (2000) 1.43
Colles' fracture and subsequent hip fracture risk. Clin Orthop Relat Res (1983) 1.43
In vitro complex formation and biodistribution of mouse antitumor monoclonal antibody in cancer patients. J Nucl Med (1989) 1.43
Radioimmunoassay of parathyroid hormone in hypercalcemic patients with malignant disease. Am J Med (1974) 1.42
Measurement of bone mineral content in human vertebrae and hip by dual photon absorptiometry. Radiology (1980) 1.42
In vivo fate of monoclonal antibody B72.3 in patients with colorectal cancer. J Nucl Med (1990) 1.41
L-glyceric aciduria. A new genetic variant of primary hyperoxaluria. N Engl J Med (1968) 1.41
Leptin reduces ovariectomy-induced bone loss in rats. Endocrinology (2001) 1.40
Three-year follow-up on effects of transdermal estrogen. Ann Intern Med (1996) 1.39
beta-Adrenergic blocking agents. 16. 1-(Acylaminomethyl-, ureidomethyl-, and ureidoethylphenoxy)-3-amino-2-propanols. J Med Chem (1977) 1.39